Moderna Plunged 17.45% After Cancer Vaccine Data Leaked Early

After-the-fact Expert

Moderna stock crashed after a third party leaked cancer vaccine data ahead of a highly anticipated presentation. The positive study showed that Moderna’s shot combined with Keytruda cut the risk of melanoma relapse or death by 42%, meeting Wall Street expectations. One analyst characterized the decline as a “sell-the-news reaction,” with shares falling as much as 25% during the session.  For informational and educational purposes only. Not financial advice.  #Moderna #MRNA #Biotech #StockMarket

Transcript

00:00Moderna plunged 17.45% today. What happened?

00:05Moderna develops vaccines and other medicines that use messenger RNA to instruct the body to fight infectious diseases and cancer.

00:15What happened was a third-party leak got ahead of a highly anticipated presentation of cancer vaccine data from Moderna

00:23and Merck.

00:24According to Yahoo!, the sell-off coincided with that early release, which took some of the impact out of the

00:31formal unveiling.

00:33Moderna develops messenger RNA vaccines and medicines for infectious diseases and cancer.

00:40What's still unclear is whether the leak alone explains the full stock reaction or how investors interpreted the underlying data.

00:49Healthcare rose 1.34% today, so this move ran against its own sector.

00:56A new post-market recap every trading day.

Category

Transcript

Comments

Recommended